857 related articles for article (PubMed ID: 7994754)
1. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
[TBL] [Abstract][Full Text] [Related]
2. The immunostimulatory compound 7-allyl-8-oxoguanosine (loxoribine) induces a distinct subset of murine cytokines.
Pope BL; MacIntyre JP; Kimball E; Lee S; Zhou L; Taylor GR; Goodman MG
Cell Immunol; 1995 May; 162(2):333-9. PubMed ID: 7743561
[TBL] [Abstract][Full Text] [Related]
3. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
[TBL] [Abstract][Full Text] [Related]
4. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
Pope BL; Chourmouzis E; Victorino L; MacIntyre JP; Capetola RJ; Lau CY
J Immunol; 1993 Sep; 151(6):3007-17. PubMed ID: 8376766
[TBL] [Abstract][Full Text] [Related]
5. Selective modulation of elements of the immune system by low molecular weight nucleosides.
Goodman MG; Reitz AB; Chen R; Bobardt MD; Goodman JH; Pope BL
J Pharmacol Exp Ther; 1995 Sep; 274(3):1552-7. PubMed ID: 7562533
[TBL] [Abstract][Full Text] [Related]
6. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice.
Sharma BS; Mhaskar S; Balazs L; Siaw M
Immunopharmacol Immunotoxicol; 1992; 14(1-2):1-19. PubMed ID: 1597650
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of immunostimulatory activity by dual substitution of C8-substituted guanine ribonucleosides: correlation with increased cytokine secretion.
Pope BL; Chourmouzis E; Lee S; Goodman MG
J Immunother Emphasis Tumor Immunol; 1995 Feb; 17(2):98-108. PubMed ID: 7647961
[TBL] [Abstract][Full Text] [Related]
9. Topology of the loxoribine binding site. Studies with inactive loxoribine analogues.
Goodman MG; Goodman JH
J Immunol; 1994 Nov; 153(9):4081-7. PubMed ID: 7930614
[TBL] [Abstract][Full Text] [Related]
10. A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine.
Goodman MG
Pharm Biotechnol; 1995; 6():581-609. PubMed ID: 7551237
[TBL] [Abstract][Full Text] [Related]
11. In vivo enhancement of murine natural killer cell activity by 7-allyl-8-oxoguanosine (loxoribine).
Pope BL; Chourmouzis E; Sigindere J; Capetola RJ; Lau CY
Int J Immunopharmacol; 1992 Nov; 14(8):1375-82. PubMed ID: 1464469
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine. II. Characterization of induced effector cells and the mechanism of induction.
Sharma BS; Mhaskar S; Balazs L; Jin A; Smee DF
Immunopharmacol Immunotoxicol; 1992; 14(1-2):21-38. PubMed ID: 1375956
[TBL] [Abstract][Full Text] [Related]
13. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; AntĂșnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
14. Local and systemic immune response to inactivated Candida albicans in mice.
Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P
Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818
[TBL] [Abstract][Full Text] [Related]
15. Genetic control of the natural killer cell activity in SJL and other strains of mice.
Kaminsky SG; Nakamura I; Cudkowicz G
J Immunol; 1985 Jul; 135(1):665-71. PubMed ID: 3923115
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer.
Hunter CA; Timans J; Pisacane P; Menon S; Cai G; Walker W; Aste-Amezaga M; Chizzonite R; Bazan JF; Kastelein RA
Eur J Immunol; 1997 Nov; 27(11):2787-92. PubMed ID: 9394800
[TBL] [Abstract][Full Text] [Related]
17. Antimetastatic effect of CpG DNA mediated by type I IFN.
Hafner M; Zawatzky R; Hirtreiter C; Buurman WA; Echtenacher B; Hehlgans T; MĂ€nnel DN
Cancer Res; 2001 Jul; 61(14):5523-8. PubMed ID: 11454702
[TBL] [Abstract][Full Text] [Related]
18. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
19. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
Kaminsky SG; Nakamura I; Cudkowicz G
J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756
[TBL] [Abstract][Full Text] [Related]
20. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
Lauwerys BR; Renauld JC; Houssiau FA
Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]